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Polycythemia is rarely associated with pheochromocytoma.?A patient 
with a 22-year history of malignant pheochromocytoma is presented in 
whom major complications developed as a result of long-standing 
polycythemia, apparently due to secretion of erythropoietin by the 
tumors, Despite attempts to reduce tumor burden by surgery, chemo- 
therapy, and large doses of I- 13 1 -metaiodobenzylguanidine, polycy- 
themia persisted. Extensive venous thromboks developed ,requiring 
hospitalization and anticoagulation. Thus, polycythemia l&elf may be a 
cause, of major morbidity in patients with pheochromocytoma, and 
prophylactic measures may be warranted. Review of the 130 patlents 
with benign and mallgnant pheochromocytoma studied since the intro- 
duction of I- 131 -metaiodobenzylguanidine in 198d revealed another 
six patients with hematocrits over 50 but only one had a hematocrit 
greater than 55 and required regular phlebotomy. In contrast, anemia 
(hematocrlt less than 35) due to variety of causes was present in 18 
cases. 
The deleterious effects of pheochromocytoma are usually directly attrib- 
utable to the excessive secretion of catecholamines [ 1,2]. More rarely, 
pheochiomocytomas may secrete other hormones including ACTH, 
growth hormone-releasing hormone, somatostatin, vasoactive intestinal 
polypeptide, and possibly substance P and motilin, which may them- 
selves cause additional syndromes [3-81. We present a patient with 
malignant, widespread pheochromocytoma in whom major complica- 
tions developed as a result of long-standing potycythemia, apparently 
caused by erythropoietin produced by the tumor. 
CASE REPORT 
A 32-year-old black man experienced palpitations, diaphoresis, hyperten- 
sion, and epistaxis at the age of 10 in 1964. The hemoglobin level was 21.8 
g/liter (Table I). Multiple abdominal pheochromocytomas were excised and 
further excisions were attempted two years later. Hemoglobin and hemato- 
crit subsequently declined. Pulmonary m&stases developed, followed by 
skull lesions five years later. In 1975, the patient underwent a chemothera- 
peutic trial of streptozotocin, carmustine (1,3-bis-[2-chloroethyl]-l-nitro- 
sourea), and vincristine. In 1977, polycythemia was again noted. In 1980, 
his hematocrit rose to 73. Arterial blood gases on room air at pH 7.42 were 
as follows: oxygen partial pressure of 80 mm Hg, carbon dioxide partial 
pressure of 40 mm Hg, and oxygen saturation of 95 percent. Bone marrow 
examination showed increased cellularity, of which 58 percent was eryth- 
ropoietic, 41 percent was granulopoietic, and 1 percent was lymphoid 
(myeloid: erthyroid ratio 0.7, normal 3:l to 4:l) 191, indicating marked 
expansion of the erythron. Megakaryocytes were nornial and trace 
amounts of iron were found in the bone marrow. Hemoglobin electrophore- 
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TABLE I Hematoiogic Profile 
White Blood 
Clinical Course Age Hemoglobin Hemalocrit Cell Count Platelet Count Erythropoletln 
Presentation 1964 10 21.6 - 5.5 - - 
Repeat abdominal surgery 1966 12 15.4 51 8.1 - - 
Repeat abdominal surgery 1967 13 12.2 39 5.5 - - 
Repeat abdominal surgery 1969 15 11.9 36 - - - 
Chemotherapy 1977 23 19 58 3.2 265 - 
131-I-MIBG 1981 27 22 70 2.5 136 - 
131-I-MIBG 1982 28 22.6 70 2.3 117 - 
68 56 
70 50 
131~I-MIBG 1984 29 21.2 66.5 2.5 135 - 
Edema, venous thrombosis 1986 31 19.1 60 4.2 126 - 
(Discharge) 46” 
MIBG = metaiodobenzylguanidine. 
* Following therapeutic phlebotomy. 
sis was normal (hemoglobin A, 97.5 percent and hemoglo- 
bin A2 2.2 percent): the oxygen dissoctation curve showed a 
P50 of 29.2 mm Hg (normal, 27.2 f 1.8 mm Hg, f 2 SD) 
[lo], which was believed to be normal. Red blood cell 
mass, determined by chromium-labeled red blood cells, 
was 4,054 ml (normal, 1,873 to 2,045 ml), plasma volume 
by radioiodinated albumin tias 2,900 ml (normal, 2,048 to 
2,944 ml), and whole blood volume was 6,950 ml (normaJ, 
4,082 to 4,990). The patient subsequently received high- 
dose I-13%metaiodobenzylguanidine in an attempt to re- 
duce the tumor burden and catecholamine production [ Ill. 
Figure 1 shows the multiple sites of metastatic involvement 
detected following the second therapeutic dose. A total of 
606 mCi of I-13Lmetaiodobenzylguanidine was’adminis- 
tered in four treatments from 1980 to 1984. Plasma and 
urine catecholamine. levels were very high (Table II). In 
1982, the erythropoietin level was 56 pU/ml (normal, 7 to 
33 &l/ml; Bioscience, Van Nuys, California) at which time 
the hematocrit was 68. The repeat erythropoietin level was 
50 pU/ml, while the hematocrit was 70. Blood pressure 
was controlled with 100 mg of phenoxybenzamine daily. 
The patient irregularly presented for follow-up but main- 
tained two jobs. However, frequent calls from pharmacists 
questioning the dose of phenoxybenzamine and the fre- 
quent prescription refills suggested compliance with the 
antihypertensive regimen. 
At age 31, the patient experienced right lower quadrant 
pain and returned for follow-up. Blood pressure was 120/74 
mm Hg, and the pulse was 70 beats/minute. Nodules were 
palpable over the right and left parietal regions of the scalp. 
The abdomen was tender to palpation of the right lower 
quadrant, but guarding and rebound were absent. The 
spleen was not enlarged. The extremities were not edema- 
tous. Chest radiographs showed multiple pulmonary nod- 
ules consistent with metastatic pheochromocytoma. The 
admission hematocrit was 60. The following day, edema of 
the right lower extremity developed. Ultrasonography 
showed extensive venous thrombosis including the infrar- 
enal inferior vena cava, right common femoral, and.right 
inferior epigastric veins. Computed tomography showed 
bilateral parietai skull metastases. The patient was treated 
with intravenous heparin, phlebotomy, and ,subsequentiy 
warfarin. The hospital course was unremarkable. Dis- 
charge hematocrit was 46. He returned to the emergency 
services area five days later complaining of lower extremity 
edema after standing several hours at work. His legs were 
Figure 1. Total body image obtained 
two days after the intraven,obs’ adminis- 
tration of 98 mCi of I- 13 I-metaiodobe% 
zylguanidine. Arrows ‘indicate the loca- 
t/on of the rjght should& and right iliac 
crest. Each of ttie f&a/ areas, of uptake 
represents a metastatic deposit. Multiple 
lesions are seen in the skull, including 
the very large area superiorly with in- 
tense uptake, the thoracic and lumbar 
spine, ribs, pelvis, and femurs, indicating 
extensive disease. 
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nontender and the results of pulmonary examination were 
unremarkable. These findings were attributed to venous 
insufficiency. The patient has not kept subsequent appoint- 
ments and serial phlebotomies have not been performed as 
p!anned. 
COMMENTS 
The association of polycythemia and pheochromocytoma 
is rare. Of 130 patients with benign and malignant pheo- 
chromocytomas evaluated at this institution since the 
introduction of I- 13 l-metaiodobenrylguanidine in 1980, 
for whom hematologic data are available, only six patients 
have had hematocrits greater than 50; all, however, ex- 
cept for the patient described herein, have had hemato- 
crits less than 55. This includes a 25year-old man whose 
polycythemia was discovered eight years prior to the 
diagnosis of pheochromocytoma. His hematocrit at age 8 
was 73 and has been controlled for the past 13 years by 
periodic phlebotomy. 4s with the previous patient, results 
of pulmonary function, blood gases, hemoglobin electro- 
phoresis, and oxygen dissociation studies were all nor- 
mal. Erythropoietin levels yere not, however, measured. 
The observed increases in hematocrit may be more 
commonly due to reduction in plasma volume [ 121 and 
less frequently to expansion of red cell mass. Pheochro- 
mocytoma has been found in association with von Mippel- 
Landau disease [ 131, in which case the cerebellar heman- 
gioblastomas that may occur appear to secrete an eryth- 
ropoietin-like substance. Erythropoietin-like activity has 
been extracted from the pheochromocytomas of patients 
with polycythemia [ 141, and resolution of- the polycythe- 
mia occurs when the tumor is tolally removed.[ 12,14,15]. 
The syndrome differs from qolycythemia vera by the lack 
of splenomegaly, or increases in leukocyte or platelet 
counts, and, a$ in this case,“by the demonstration of 
excessive and inappropriate circulating erythropoietin im- 
munoactivity. Other causes of polycythemia with elevated 
erythropoietin activity, such as chronic hypoxia and he- 
moglobinopathies, are not present. 
In patients with pheochromocytoma, anemia occurs 
much more commonly than polycythemia. We observed 
18 patients with pheochromocytoma in whom at least one 
hematocrit determination was less than 35. There are 
multiple causes, including prior chemotherapy and proba- 
ble tumor-induced iron reutilization effects, but the most 
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TABLE II Levels of Plasma and Urinary 
Catecholamlnes and Derivatives* 
1980 1982 1984 1988 
Plasma 
Norepinephrine 25,314 28,920 16,758 5,594 
(GO0 pg/ml) 
Epinephrine 618 406 269 261 
(<IO0 pg/ml) 
Urine 
Norepinephrine 2,956 2,467 1,570 - 
(< 110 pg/24 hr) 
Epinephrine 102 230 4 - 
(<30 pg124 hr) 
Normetanephrine 1,628 1,937 467 - 
(< 165 pg/24 hr) 
Metanephrine 782 22 6 - 
(<85 pg/24 hr) 
Vanillylmandelic acid 96 92 22 - 
(<7 ing/24 hr) 
l Normal values are listed in parentheses. 
common cause appears to be extensive phlebotomy dur- 
ing evaluation. 
The low leukocyte count in our patient and the decline 
in circulating platelets were likely due to prior chemo- 
therapy and to the effects of high doses of I- 13 l-metaio- 
dobenzylguanidine upon the bone marrow. Despite this 
patient’s large tumor burden and massive catecholamine 
production, his blood pressure is controlled and he contin- 
ues to work. To our knowledge, however, this is the first 
demonstration of excessive erythropoietin immunoactivity 
in the circulation of a patient with pheochromocytoma and 
polycythemia. The levels of erythropoietin immunoreac- 
tivity, most likely secreted by the tumors, were moderate- 
ly elevated and, given the elevated hematocrit and the 
normal oxygen delivery, strikingly inappropriate and au- 
tonomous. Complications from the polycythemia can oc- 
cur [ 161 and, thus, the polycythemia of pheochromocyto- 
ma may require prophylactic measures to prevent unto- 
ward events. 
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